No substitutes available
Jakavi 20mg Tablet contains Ruxolitinib, a targeted anticancer medicine belonging to the class of kinase inhibitors. It is commonly prescribed for conditions where the bone marrow does not function properly, such as myelofibrosis and polycythemia vera, especially in patients who cannot tolerate or do not respond well to hydroxyurea. Jakavi is also used to manage acute and chronic graft-versus-host disease (GvHD) in adults and children aged 12 years and older who have not improved with earlier treatments. By blocking abnormal signals that trigger excessive cell growth, Jakavi helps relieve symptoms, improve blood counts, and reduce disease-related complications.
Jakavi 20mg Tablet is used to treat the following conditions:
Ruxolitinib works by blocking the overactive JAK1 and JAK2 enzymes that regulate blood cell production and immune activity. By slowing abnormal blood cell growth, reducing the risk of blood clots in polycythemia vera, easing symptoms like spleen enlargement and fatigue, and controlling immune-related damage in GvHD, Jakavi helps improve overall quality of life and slow disease progression.
Side Effects of Jakavi 20mg Tablet
Like all medications, Jakavi 20mg Tablet may cause side effects. However, not everyone will experience them.
Serious Side Effects (Seek immediate medical attention):
Common Side Effects (Usually mild and temporary):
Jakavi 20mg Tablet should be taken orally exactly as prescribed, with your doctor determining the dose based on your disease severity, blood test results, treatment response, and kidney or liver function. Swallow the tablet whole with water, with or without food, at the same time each day, and avoid chewing or crushing it. If you miss a dose, simply take the next one as scheduled never double the dose.
The medicine can pass into breast milk. Avoid breastfeeding during treatment and for 2 weeks after the last dose.
The safety of alcohol use with Jakavi is not established. Consult your doctor before consuming alcohol.
Use cautiously if you have lung conditions. Always inform your doctor of your medical history.
Jakavi may cause dizziness. Avoid driving or using heavy machinery if you feel lightheaded.
Jakavi may harm the unborn baby. Do not take this medicine if you are pregnant or planning pregnancy.
Jakavi blocks overactive JAK1/JAK2 enzymes, helping control abnormal blood cell growth and reducing symptoms like spleen enlargement and fatigue.
Most patients feel better within 2–4 weeks, while major improvements—like reduced spleen size—may take 2–3 months.
Yes. Jakavi can slightly weaken your immune system, making infections like shingles or colds more likely. Regular monitoring is important.
Your doctor may lower the dose, pause treatment, or monitor you more closely until blood counts stabilize.
Yes. Drugs affecting CYP3A4 and foods like grapefruit can change Jakavi levels. Always inform your doctor about all medicines and supplements.
| Active ingredient | Ruxolitinib |
| Pharmacologic class | Kinase inhibitors |
| Medication category | ANTI NEOPLASTICS |
| Dosage forms | Tablet |
The information on the Phoenix Pharmex website is shared for educational purposes only and is not a substitute for professional medical advice or treatment. Always consult a doctor for any health-related questions. Please avoid self diagnosis or delaying medical care based on this content. Our mission is to support informed decisions not replace professional medical guidance.
Azadine 100mg Injection contains Azacitidine which belongs to the group of medicines called Anticancer agents. It is used in adults to treat all sub-types of myelodysplastic syndromes (MDS; group of cancers associated with blood and bone marrow) and certain types of blood cancers known as Chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML).
Azadine 100mg Injection is typically used in adults who cannot undergo stem cell transplantation. It may be also used to treat other conditions, as determined by the doctor.
Azadine Injection is given as an injection under the medical supervision of a doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised.
You must inform your doctor before taking any vaccination while on treatment with this medicine. Regular blood tests are required to check your blood cells along with the heart, liver, and kidney.
Before taking it, tell your doctor if you have liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your doctor know all medications you are using.
Azadine 100mg Injection is an anticancer medication. It works by blocking the actions of certain enzymes (DNA/RNA methyltransferase) within the cancer cells that is required for the cells to grow and multiply. It also reduces the production of new genetic material (RNA and DNA) within the cells. As a result, it prevents abnormal cell division within the body, slows down the growth of cancer cells and helps the bone marrow to produce normal blood cells.
It is used to treat:
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Ques 1: What is the use of AZADINE 100MG INJECTION?
Ans :AZADINE 100MG INJECTION is used in adults to treat all sub-types of myelodysplastic syndromes (MDS; group of cancers associated with blood and bone marrow) and certain types of blood cancers known as Chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML).
Ques 2: How does AZADINE 100MG INJECTION works?
Ans :AZADINE 100MG INJECTION is an anticancer medication. It works by blocking the actions of certain enzymes (DNA/RNA methyltransferase) within the cancer cells that is required for the cells to grow and multiply. It also reduces the production of new genetic material (RNA and DNA) within the cells. As a result, it prevents abnormal cell division within the body, slows down the growth of cancer cells and helps the bone marrow to produce normal blood cells.
Ques 3: Can I take AZADINE 100MG INJECTION during breastfeeding?
Ans :No. AZADINE 100MG INJECTION is not recommended for use in breast-feeding women. Therefore, inform your doctor before receiving it.
Ques 4: Can AZADINE 100MG INJECTION increase the risk of infections?
Ans :AZADINE 100MG INJECTION may cause a drop in the number of white blood cells in the body and may weaken your immune system. As a result, you may be at a greater risk of getting infected while receiving AZADINE 100MG INJECTION. To avoid this, your doctor will regular monitor your blood counts as a precaution. However, inform your doctor if you experience any signs of infection such as fever.
Ques 5: Can the use of AZADINE 100MG INJECTION make me feel tired?
Ans :Yes. AZADINE 100MG INJECTION may make you feel tired easily. This is because, it reduces the levels of red blood cells in your blood and may make you anemic. Consult your doctor if you experience tiredness after receiving AZADINE 100MG INJECTION. Tiredness can also occur if you have any pre-existing disease conditions such as liver or kidney impairment while receiving this medicine.
Ques 6: Can I drive a car after receiving AZADINE 100MG INJECTION?
Ans :AZADINE 100MG INJECTION may make you feel tired or weak. Therefore, do not drive or operate any heavy tools or machines if your ability is affected by AZADINE 100MG INJECTION.
Ques 7: How AZADINE 100MG INJECTION is administered?
Ans :AZADINE 100MG INJECTION will be given to you only by a doctor or a nurse beneath the skin (subcutaneously) of thighs, arms or abdomen.
Ques 8: How to control nausea caused due to AZADINE 100MG INJECTION?
Ans :Generally, anticancer medicines are associated with uncontrollable nausea and vomiting. To avoid this, your doctor would prescribe a suitable medicine to control them along with AZADINE 100MG INJECTION. If not, consult your doctor for a suitable anti-emetic medicine. Do not self-treat nausea.
Jakavi 20mg Tablet contains Ruxolitinib, a targeted anticancer medicine belonging to the class of kinase inhibitors. It is commonly prescribed for conditions where the bone marrow does not function properly, such as myelofibrosis and polycythemia vera, especially in patients who cannot tolerate or do not respond well to hydroxyurea. Jakavi is also used to manage acute and chronic graft-versus-host disease (GvHD) in adults and children aged 12 years and older who have not improved with earlier treatments. By blocking abnormal signals that trigger excessive cell growth, Jakavi helps relieve symptoms, improve blood counts, and reduce disease-related complications.
Jakavi 20mg Tablet is used to treat the following conditions:
Ruxolitinib works by blocking the overactive JAK1 and JAK2 enzymes that regulate blood cell production and immune activity. By slowing abnormal blood cell growth, reducing the risk of blood clots in polycythemia vera, easing symptoms like spleen enlargement and fatigue, and controlling immune-related damage in GvHD, Jakavi helps improve overall quality of life and slow disease progression.
Side Effects of Jakavi 20mg Tablet
Like all medications, Jakavi 20mg Tablet may cause side effects. However, not everyone will experience them.
Serious Side Effects (Seek immediate medical attention):
Common Side Effects (Usually mild and temporary):
Jakavi 20mg Tablet should be taken orally exactly as prescribed, with your doctor determining the dose based on your disease severity, blood test results, treatment response, and kidney or liver function. Swallow the tablet whole with water, with or without food, at the same time each day, and avoid chewing or crushing it. If you miss a dose, simply take the next one as scheduled never double the dose.
The medicine can pass into breast milk. Avoid breastfeeding during treatment and for 2 weeks after the last dose.
The safety of alcohol use with Jakavi is not established. Consult your doctor before consuming alcohol.
Use cautiously if you have lung conditions. Always inform your doctor of your medical history.
Jakavi may cause dizziness. Avoid driving or using heavy machinery if you feel lightheaded.
Jakavi may harm the unborn baby. Do not take this medicine if you are pregnant or planning pregnancy.
Jakavi blocks overactive JAK1/JAK2 enzymes, helping control abnormal blood cell growth and reducing symptoms like spleen enlargement and fatigue.
Most patients feel better within 2–4 weeks, while major improvements—like reduced spleen size—may take 2–3 months.
Yes. Jakavi can slightly weaken your immune system, making infections like shingles or colds more likely. Regular monitoring is important.
Your doctor may lower the dose, pause treatment, or monitor you more closely until blood counts stabilize.
Yes. Drugs affecting CYP3A4 and foods like grapefruit can change Jakavi levels. Always inform your doctor about all medicines and supplements.
| Active ingredient | Ruxolitinib |
| Pharmacologic class | Kinase inhibitors |
| Medication category | ANTI NEOPLASTICS |
| Dosage forms | Tablet |
The information on the Phoenix Pharmex website is shared for educational purposes only and is not a substitute for professional medical advice or treatment. Always consult a doctor for any health-related questions. Please avoid self diagnosis or delaying medical care based on this content. Our mission is to support informed decisions not replace professional medical guidance.
Life-Saving Medicines Expert
Affordable Patient-Centered Care
Authentic, Top-Quality Medicines
Careful & Timely Medicine Deliveries
Login with Facebook
Login with Google
